Market Tracker

07/23 9:58am ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

132.00
Real-Time Quote
 +0.74 / +0.56%
Today’s Change
64.93
Today|||52-Week Range
141.81
+46.76%
Year-to-Date

Today’s Trading

Previous close131.26
Today’s open131.96
Day’s range130.26 - 134.24
Volume42,807
Average volume (3 months)1,112,974
Market cap$8.3B
Dividend yield--
Data as of 9:41am ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+73.38%
Earnings growth (next 5 years)+18.40%
Revenue growth (last year)+26.98%
P/E ratio117.7
Price/Sales5.95
Price/Book11.15

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc-0.37-0.73%
INCYIncyte Corp+0.57+1.19%
JAZZJazz Pharmaceuticals...+2.65+1.82%
BMRNBiomarin Pharmaceuti...+2.60+4.31%
Data as of 9:58am ET, 07/23/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)$1.69
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts